Registry of Toxic Effects of Chemical Substances (RTECS)
s-Triazole, 3-amino-
RTECS #
XZ3850000CAS #
61-82-5; 155-25-9Updated
September 201Molecular Weight
84.10Molecular Formula
C2H4N4Synonyms
1H-1,2,4-Triazol-3-amine3,A-T
3-Amino-1,2,4-triazole
3-Amino-1,2,4-triazole (ACGIH)
3-Amino-1H-1,2,4-triazole
3-Amino-s-triazole
3-Aminotriazole
Amino triazole weedkiller 90
Aminotriazole (plant regulator)
Aminotriazol-spritzpulver
Amitol
Amitrol
Amitrol 90
Amitrole
Amitrole (ACGIH)
Amitrol-T
Amizol
AT
ATA
Campaprim A 1544
Cytrol
Cytrole
Diurol
Diurol 5030
Elmasil
Emisol
Emisol 50
Emisol F
ENT 25445
Herbidal total
Herbizole
Kleer-lot
Orga-414
Radoxone TL
Ramizol
RCRA waste number U011
Simazol
Solution concentree T271
Triazolamine
USAF XR-22
Vorox
Vorox AA
Vorox AS
Weedar ADS
Weedar AT
Weedazin
Weedazin arginit
Weedazol
Weedex granulat
X-All liquid
Mutation Data and Reference
System Test | Route/Organism/Tissue | Dose | Reference |
---|---|---|---|
DNA adduct | /Escherichia coli | 10 µmol/L | MUREAV 89,95,1981 |
DNA Damage | /Bacillus subtilis | 1 mg/disc | PMRSDJ 1,175,1981 |
DNA Damage | liver/human | 0.1 mmol/l/48H | MUREAV 696,21,2010 |
DNA inhibition | fibroblast/human | 100 mmol/L | MUREAV 183,89,1987 |
DNA repair | /Saccharomyes cerevisiae | 100 mg/L | PMRSDJ 1,502,1981 |
gene conversion and mitotic recombination | /Saccharomyes cerevisiae | 300 mg/L | PMRSDJ 1,491,1981 |
gene conversion and mitotic recombination | /Aspergillus nidulans | 600 µg/L | MUREAV 147,288,1985 |
host-mediated assay | Salmonella typhimurium/mouse | 12 mg/kg | JJIND8 62,911,1979 |
morphological transform | embryo/hamster | 10 mg/L | TOLED5 7,211,1981 |
morphological transform | kidney/hamster | 250 mg/L | PMRSDJ 1,638,1981 |
morphological transform | embryo/rat | 80 mg/L | JJIND8 67,1303,1981 |
morphological transform | embryo/mouse | 125 mg/L | EMMUEG 12,21,1988 |
morphological transform | fibroblast/mouse | 0.01 mg/L/21D (-enzymatic activation step) | EMMUEG 35,300,2000 |
mutation in mammalian somatic cells | embryo/hamster | 1 mg/L | MUREAV 140,205,1984 |
mutation in microorganisms | /Other microorganisms | 1 mg/plate (-enzymatic activation step) | MUREAV 57,277,1978 |
mutation in microorganisms | /Salmonella typhimurium | 50 µg/plate (-enzymatic activation step) | PMRSDJ 1,351,1981 |
mutation in microorganisms | /Escherichia coli | 50 µg/plate (+enzymatic activation step) | PMRSDJ 1,351,1981 |
mutation in microorganisms | /Saccharomyes cerevisiae | 840 mg/L/16H | MUTAEX 20,105,2004 |
phage inhibition capacity | /Escherichia coli | 15 gm/L | VIRLAX 99,257,1979 |
sex chromosome loss and nondisjunction | /Saccharomyes cerevisiae | 50 mg/L | PMRSDJ 1,468,1981 |
sex chromosome loss and nondisjunction | /Aspergillus nidulans | 600 µg/L | MUREAV 147,288,1985 |
specific locus test | oral/Drosophila melanogaster | 500 µmol/L | MUREAV 242,169,1990 |
Reproductive Effects Data and References
Route/Organism | Dose | Effect | Reference |
---|---|---|---|
oral/rat | 700 µg/kg (22D pregnant) | Reproductive: Specific developmental abnormalities: Endocrine system | ANREAK 145,284,1963 |
oral/mouse | 2600 mg/kg (6-18D pregnant) | Reproductive: Effects on embryo or fetus: Fetotoxicity (except death, e.g., stunted fetus) | ARTODN 33,41,1974 |
oral/mouse | 1935 mg/kg (6-14D pregnant) | Reproductive: Effects on embryo or fetus: Fetotoxicity (except death, e.g., stunted fetus) Reproductive: Effects on embryo or fetus: Fetal death | NTIS** PB223-160 |
subcutaneous/mouse | 4176 mg/kg (6-14D pregnant) | Reproductive: Effects on fertility: Litter size (e.g., # fetuses per litter; measured before birth) Reproductive: Effects on embryo or fetus: Fetotoxicity (except death, e.g., stunted fetus) Reproductive: Effects on embryo or fetus: Fetal death | NTIS** PB223-160 |
Tumorigenic Data and References
Route/Organism | Dose | Effect | Reference |
---|---|---|---|
oral/mouse | lowest published toxic dose: 113 gm/kg/3W- intermittent | Tumorigenic: Carcinogenic by RTECS criteria Liver: Tumors | JNCIAM 42,1101,1969 |
oral/mouse | toxic dose: 366 gm/kg/26W- continuous | Tumorigenic: Equivocal tumorigenic agent by RTECS criteria Liver: Tumors | TOLED5 29,145,1985 |
oral/mouse | lowest published toxic dose: 21.6 gm/kg/180D- intermittent | Tumorigenic: Neoplastic by RTECS criteria Endocrine: Thyroid tumors Tumorigenic: Increased incidence of tumors in susceptible strains | CRNGDP 30,1614,2009 |
oral/mouse | lowest published toxic dose: 21.6 gm/kg/180D- intermittent | Tumorigenic: Neoplastic by RTECS criteria Endocrine: Thyroid tumors Tumorigenic: Increased incidence of tumors in susceptible strains | CRNGDP 30,1614,2009 |
oral/rat | lowest published toxic dose: 4595 mg/kg/2.5Y- continuous | Tumorigenic: Carcinogenic by RTECS criteria Endocrine: Tumors Endocrine: Thyroid tumors | TXAPA9 69,161,1983 |
oral/rat | toxic dose: 3670 mg/kg/2Y- continuous | Tumorigenic: Neoplastic by RTECS criteria Endocrine: Thyroid tumors | SCIEAS 132,296,1960 |
oral/rat | toxic dose: 122 gm/kg/70W- continuous | Tumorigenic: Carcinogenic by RTECS criteria Endocrine: Thyroid tumors | JNCIAM 57,861,1976 |
oral/rat | toxic dose: 105 gm/kg/60W- continuous | Tumorigenic: Carcinogenic by RTECS criteria Endocrine: Thyroid tumors | NMJOAA 23,83,1978 |
Acute Toxicity Data and References
Route/Organism | Dose | Effect | Reference |
---|---|---|---|
intraperitoneal/mouse | lethal dose (50 percent kill): 200 mg/kg | NTIS** AD277-689 | |
intravenous/mouse | lethal dose (50 percent kill): >5 gm/kg | OYYAA2 13,597,1977 | |
oral/mouse | lethal dose (50 percent kill): 14700 mg/kg | PCOC** -,33,1966 | |
oral/quail | lethal dose (50 percent kill): >316 mg/kg | EESADV 6,149,1982 | |
oral/rat | lethal dose (50 percent kill): 1100 mg/kg | RREVAH 10,97,1965 | |
skin/rat | lethal dose (50 percent kill): >10 gm/kg | WRPCA2 9,119,1970 |
Other Multiple Dose Data and References
Route/Organism | Dose | Effect | Reference |
---|---|---|---|
oral/hamster | lowest published toxic dose: 4704 mg/kg/28W- continuous | Endocrine: Other changes Blood: Changes in serum composition (e.g. TP, bilirubin, cholesterol) | ARTODN 60,343,1987 |
oral/mouse | lowest published toxic dose: 14070 mg/kg/3W- continuous | Blood: Changes in other cell count (unspecified) | NSAPCC 375(Suppl 1),30,2007 |
oral/rat | lowest published toxic dose: 700 mg/kg/28D- intermittent | Endocrine: Changes in thyroid weight | ARTODN 83,459,2009 |
oral/rat | lowest published toxic dose: 3500 mg/kg/28D- intermittent | Endocrine: Evidence of thyroid hypofunction Endocrine: Changes in pituitary weight Endocrine: Changes in thyroid weight | ARTODN 83,459,2009 |
oral/rat | lowest published toxic dose: 313 mg/kg/90D- continuous | Endocrine: Thyroid weight (goiter) | JEPTDQ 1(1),147,1977 |
oral/rat | lowest published toxic dose: 300 mg/kg/3D- continuous | Endocrine: Other changes | JOENAK 94,131,1982 |
oral/rat | lowest published toxic dose: 700 mg/kg/7D- continuous | Endocrine: Thyroid weight (goiter) | JOENAK 94,131,1982 |
oral/rat | lowest published toxic dose: 26250 mg/kg/30W- continuous | Endocrine: Thyroid weight (goiter) | JJIND8 57,861,1976 |
oral/rat | lowest published toxic dose: 61250 mg/kg/70W- continuous | Endocrine: Tumors | JJIND8 57,861,1976 |
oral/rat | lowest published toxic dose: 420 mg/kg/14D- continuous | Liver: Changes in liver weight Kidney, Ureter, and Bladder: Changes in kidney weight Nutritional and Gross Metabolic: Weight loss or decreased weight gain | TXAPA9 60,45,1981 |
oral/rat | lowest published toxic dose: 168 mg/kg/4W- continuous | Nutritional and Gross Metabolic: Weight loss or decreased weight gain | JTSCDR 30,1,2005 |
oral/rat | lowest published toxic dose: 252 mg/kg/6W- continuous | Liver: Changes in liver weight Kidney, Ureter, and Bladder: Changes in kidney weight Endocrine: Changes in thyroid weight | JTSCDR 30,1,2005 |
Reviews
Organization | Standard | Reference |
---|---|---|
American Conference of Governmental Industrial Hygienists (ACGIH) | Threshold Limit Value-time-weighted average 0.2 mg/m3 | DTLVS* TLV/BEI,2013 |
American Conference of Governmental Industrial Hygienists (ACGIH) | Threshold Limit Value-Confirmed animal carcinogen | DTLVS* TLV/BEI,2013 |
International Agency for Research on Cancer (IARC) | Cancer Review:Animal Sufficient Evidence | IMEMDT 7,31,1974 |
International Agency for Research on Cancer (IARC) | Cancer Review:Animal Sufficient Evidence | IMEMDT 79,-,2000 |
International Agency for Research on Cancer (IARC) | Cancer Review:Human Inadequate Evidence | IMEMDT 7,31,1974 |
International Agency for Research on Cancer (IARC) | Cancer Review:Human Inadequate Evidence | IMEMDT 79,-,2000 |
International Agency for Research on Cancer (IARC) | Cancer Review:Group 3 | IMEMDT 79,-,2000 |
TOXICOLOGY REVIEW | DTTIAF 80,485,1973 | |
TOXICOLOGY REVIEW | 85CVA2 5,250,1970 | |
TOXICOLOGY REVIEW | MUREAV 584,1,2005 | |
TOXICOLOGY REVIEW | JTEHD6 7,1,2004 | |
TOXICOLOGY REVIEW | MUREAV 653,23,2008 | |
TOXICOLOGY REVIEW | REPTED 25,304,2007 | |
TOXICOLOGY REVIEW | HUTOX* -,551,1996 | |
TOXICOLOGY REVIEW | MUREAV 672,10,2009 | |
TOXICOLOGY REVIEW | HTOPA* 1,501,2002 | |
TOXICOLOGY REVIEW | IMEMDT 79,381, | |
TOXICOLOGY REVIEW | NBREV* 5,1,1981 | |
TOXICOLOGY REVIEW | MUREAV 653,99,2008 | |
TOXICOLOGY REVIEW | REPTED 33,188,2012 |
Standards and Regulations
Organization | Standard | Reference |
---|---|---|
Environmental Protection Agency (EPA) Federal Insecticide, Fungicide, and Rodenticide Act (FIFRA) 1988 PESTICIDE SUBJECT TO REGISTRATION OR RE-REGISTRATION | FEREAC 54,7740,1989 | |
Environmental Protection Agency (EPA) Federal Insecticide, Fungicide, and Rodenticide Act (FIFRA) 1998 STATUS OF PESTICIDES | RED Completed | RBREV* -,85,1998 |
Occupational Exposure Limit IN ARGENTINA, BULGARIA, COLOMBIA, JORDAN check ACGIH TLV; | ||
Occupational Exposure Limit IN SINGAPORE, VIETNAM check ACGIH TLV | ||
Occupational Exposure Limit-AUSTRALIA | time-weighted average 0.2 mg/m3, short term exposure limit 3 ppm, JUL2008 | |
Occupational Exposure Limit-AUSTRIA | MAK-TMW 0.2 mg/m3, inhal, 2007 | |
Occupational Exposure Limit-BELGIUM | time-weighted average 0.2 mg/m3, MAR2002 | |
Occupational Exposure Limit-DENMARK | time-weighted average 0.2 mg/m3, carc, MAY2011 | |
Occupational Exposure Limit-FRANCE | VME 0.06 ppm (0.2 mg/m3), FEB2006 | |
Occupational Exposure Limit-GERMANY | MAK 0.2 mg/m3, inhal, 2011 | |
Occupational Exposure Limit-GERMANY | MAK 0.2 mg/m3, inhal, 2011 | |
Occupational Exposure Limit-ICELAND | time-weighted average 0.2 mg/m3, NOV2011 | |
Occupational Exposure Limit-JAPAN | 2B carc, MAY2012 | |
Occupational Exposure Limit-KOREA | time-weighted average 0.2 mg/m3, 2006 | |
Occupational Exposure Limit-NEW ZEALAND | time-weighted average 0.2 mg/m3, JAN2002 | |
Occupational Exposure Limit-PERU | time-weighted average 0.2 mg/m3, JUL2005 | |
Occupational Exposure Limit-SWITZERLAND | MAK-week 0.2 mg/m3, carc 3, inhal, JAN2011 | |
Occupational Exposure Limit-THE NETHERLANDS | MAC-TGG 0.2 mg/m3, 2003 |
NIOSH Documentation and Surveillance
Organization | Standard | Reference |
---|---|---|
National Institute for Occupational Safety and Health (NIOSH) Recommended Exposure Level TO AMITROLE-air | 8H Carcinogen time-weighted average 0.2 mg/m3 | NIOSH* DHHS #92-100,1992 |
National Occupational Exposure Survey 1983 | Hazard Code 84718; Number of Industries 3; Total Number of Facilities 8; Number of Occupations 4; Total Number of Employees Exposed 693; Total Number of Female Employees Exposed 24 |
Status in Federal Agencies
- Page last reviewed:March 7, 2014
- Page last updated:February 6, 2017
- Content source:
- National Institute for Occupational Safety and Health (NIOSH) Education and Information Division